CSS
IMUX icon

Cubist Systematic Strategies’s Immunic IMUX Stock Holding History

Cubist Systematic Strategies’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,474
Closed -$16.1K – 3238
2025
Q1 		$16.1K Sell
1,474
-857
-37% -$9.25K ﹤0.01% 2753
2024
Q4 		$23.3K Sell
2,331
-1,775
-43% -$22.4K ﹤0.01% 2832
2024
Q3 		$67.8K Buy
+4,106
New +$58.5K ﹤0.01% 2736
2023
Q3 		– Sell
-1,109
Closed -$27.8K – 3622
2023
Q2 		$27.8K Buy
1,109
+832
+300% +$13.9K ﹤0.01% 3157
2023
Q1 		$4.12K Buy
+277
New +$5.14K ﹤0.01% 3760
2022
Q4 		– Sell
-535
Closed -$14.6K – 4183
2022
Q3 		$17K Hold
535
– – ﹤0.01% 4248
2022
Q2 		$19K Buy
535
+531
+13,275% +$34K ﹤0.01% 4223
2022
Q1 		$0 Buy
+4
New +$463 ﹤0.01% 3651
2021
Q2 		– Sell
-18
Closed -$3K – 2988
2021
Q1 		$3K Buy
+18
New +$3.05K ﹤0.01% 2795
2020
Q3 		– Sell
-90
Closed -$11K – 2548
2020
Q2 		$11K Buy
+90
New +$9.16K ﹤0.01% 2340

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Cubist Systematic Strategies's IMUX Position: Q2 2025 in Review

Cubist Systematic Strategies sold out of Immunic (IMUX) in Q2 2025, closing a stake of 1,474 shares — an estimated $16.1K sold.

Cubist Systematic Strategies first reported a position in IMUX in Q2 2020 and held it in 10 quarters. The position peaked at $67.8K in Q3 2024. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2025.

  • Cubist Systematic Strategies reported no remaining Immunic position as of Q2 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,474 Immunic shares in Q2 2025, an estimated $16.1K.
  • Cubist Systematic Strategies first reported a position in Immunic in Q2 2020 and held it in 10 quarters.
  • Cubist Systematic Strategies's Immunic position peaked at $67.8K in Q3 2024.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2025.

Based on Cubist Systematic Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.